ArticleBreast cancer research and treatment2025

Pathological complete response and survival outcomes in single hormone receptor-positive/HER2-negative breast cancer after neoadjuvant chemotherapy and its intrinsic biological features and immune landscape.

Lei Ji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.